drugset / Trial / NCT00711880

A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia.

NCT00711880

Phase 3 Completed 125 enrolled Jazz Pharmaceuticals
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The purpose of this study is to evaluate the efficacy of Sativex® compared with placebo in relieving peripheral neuropathic pain associated with allodynia.

Timeline

Start
2002-05
Primary completion
2004-03
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Nabiximols Other / unclassified Other

Indications